CANCER BUZZ PODCAST

Dr. Sarah Hudson-DiSalle, member of the Reimbursement and Economics Subcommittee of ACCC’s Governmental Affairs Committee, about this week’s Hill Day, when members of ACCC met with Capitol Hill offices to advocate on behalf of patients.

Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ features an update from the White House on the Biden Cancer Moonshot program.

Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Dr. Mandi Pratt-Chapman about new patient navigation payments.

Live this week from the ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ interviews Wendi Waugh, ACCC financial navigation committee member, about resources for financial advocacy.

Recent advancements in treatment and a multimodal approach to care are improving outcomes for patients with head and neck cancer, however access to therapies and unique patient challenges and other psychosocial factors can reduce patient quality of life.

Founded in 2019, this inclusive lab is comprised of 42 members ranging from undergraduates to faculty from 12 different countries, most of whom self-identify as women and/or individuals who are under-represented in medicine.

Hereditary breast cancer is a significant concern, with BRCA1 and BRCA2 mutations accounting for many inherited breast cancer cases.

In this podcast, Mila Felder, MD, FACEP, teases her keynote at the ACCC 50th Annual Meeting & Cancer Center Business Summit, why it’s important to attend this session in person, and what she’s looking forward to most at the meeting.

CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.

In this episode, CANCER BUZZ speaks with David L. Porter, MD, director of Cell Therapy and Transplant at Penn Medicine.

The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises.

At ACCC’s 40th Annual NOC, an exclusive EHR Working Summit was held to understand barriers to integrating biomarker testing into EHR systems and explore effective practices/workaround solutions to facilitate timely and comprehensive biomarker testing.

In 2020, this community-based cancer program started laying the foundation for a disease-site specific oncology patient navigation program that would grow exponentially over the next 2 years.

Listen as we discuss germline and somatic testing for patients with ovarian cancer.

Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients.

CANCER BUZZ interviews Doug Flora, MD about AI in Precision Oncology, the first- ever peer-reviewed journal on the topic.

CANCER BUZZ interviews Karline Paul, Associate Operating Officer at Vanderbilt University Medical Center, about the ways technology can support—not replace—the oncology workforce.

ACCC was invited to share the association’s key priorities for impacting cancer care in the US. ACCC president Olalekan Ajayi, PharmD, MBA, and chief operating officer at Highlands Oncology Group, PA, discusses the meeting and these initiatives.

CANCER BUZZ interviews Debbie Rimmele, Nurse Retention Specialist at the Loyola University Medical Center, about recruiting strategies and her session at the NOC: Looking Under the Hood of the Employment Process.

CANCER BUZZ interviews Steve Kennedy, Senior Vice President of Human Resources at Tennessee Oncology, about his session: Leadership Engagement and Sustainment During Challenging Times.

Live this week from the ACCC 40th National Oncology Conference, CANCER BUZZ  interviews Dr. Michael Gieske about best practices to increase lung cancer screenings and ACCC’s Rural Appalachian Lung Screening Initiative.

CANCER BUZZ previews the sessions, people and topics of this week’s ACCC 40th National Oncology Conference. We interview Kathy Oubre, MS, CEO of the Pontchartrain Canter Center, about helping patients overcome access barriers to biomarker testing.

Hear Dr. Margaret Liang, of Cedars-Sinai Cancer Center, Los Angeles, talk about ACCC’s Financial Advocacy Network (FAN) and the Financial Advocacy Services guidelines to help cancer programs address the growing issue of financial toxicity.

Disparities in bladder cancer care persist, especially with respect to race. In fact, patient demographics has a proven impact on health outcomes.

It is important for the cancer team to be able to recognize what a small cell might look like — such as central location of the tumor, bulky adenopathy generally.

This cancer program used a business intelligence-enabled dashboard to collect and analyze data on emergency department (ED) visits, admits, and discharges.

CANCER BUZZ speaks with Farrukh T. Awan, MD, MS about an approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.

"Many caregivers have it together, they’re on top of everything. They are organized, they are experts at this, but they are falling apart inside. You aren’t going to know if you don’t ask."

Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment.

Lipson Cancer Institute adapted the University of Washington’s Collaborative Care model to embed counseling services into oncology and palliative care across 6 clinic locations.